Tirzepatide: a systematic update
A 2025 review in Frontiers describing the research progress in the pathophysiological mechanisms of Type 2 diabetes framed this as an integrated picture
Contact your doctor immediately if you experience: Severe or persistent headaches Blurred vision or confusion Dizziness or fainting Nausea and vomiting that prevent hydration Signs of an allergic reaction (rash, swelling, or difficulty breathing) These could indicate more serious side effects of semaglutide or other potential complications requiring professional medical advice
Retatrutide (20 mg) is a synthetic peptide designed for metabolic and endocrine research
A schematic overview of GLP-1R agonists is summarized in Scheme 1
Results In all, 39 pwIIH (mean age 33.6 years [SD 8.0], 92.3% female, median BMI 36.3 kg/m 2 [IQR 31.438.3]) were included, with 13 pwIIH being treated with GLP-1-RAs and remaining adherent to the treatment throughout the study